Literature DB >> 23083047

Anti-annexin V antibodies in neuro-Behçet patients: clinical significance and relation to disease activity.

Tamer A Gheita, Hatem Samir, Hani Hussein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083047     DOI: 10.1111/j.1756-185X.2012.01759.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  5 in total

1.  Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG.

Authors:  Ece Erdağ; Ceren Şahin; Cem İsmail Küçükali; Sinem Bireller; Melike Küçükerden; Murat Kürtüncü; Recai Türkoğlu; Bedia Cakmakoglu; Erdem Tüzün; Feyza Arıcıoğlu
Journal:  Neurol Sci       Date:  2017-02-21       Impact factor: 3.307

Review 2.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

3.  Impact of Neuro-Behçet Disease Immunoglobulin G on Neuronal Apoptosis.

Authors:  Murat Giriş; Sinem Bireller; Cem İsmail Küçükali; Haşmet Hanağasi; Sevgin Değirmencioğlu; Erdem Tüzün
Journal:  Noro Psikiyatr Ars       Date:  2016-12-08       Impact factor: 1.339

4.  Wrist Drop as a Manifestation of Behçet's Disease.

Authors:  Angela Daher; Fady Haddad
Journal:  Eur J Case Rep Intern Med       Date:  2017-03-27

5.  Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease.

Authors:  Peng Chen; Hai Yan; Yaping Tian; Yiping Xun; Lili Shi; Ran Bao; Huai Zhang; Guangyu Chen; Chunhe Yang; Shutao Sun; Yajie Wang; Li Liu; Yabin Zhou; Chunyan Zhang; Xiaoxu Wang; Yongqiang Wen; Yongzhong Bian; Hongwu Du
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.